The rounds this investor is named on, who it invests beside, and where it shows up.
Named on one round in the feed.
New Rhein applies a private equity investment approach to life sciences venture capital investing, with a focus on later-stage, de-risked assets with proven clinical safety and efficacy.
Venture capitalnewrhein.comSince 2020-10-06
| Company | Round | Amount | Announced | Role |
|---|---|---|---|---|
Butterfly Medical A medical device company committed to reshaping the treatment of benign prostatic hyperplasia (BPH) | Series B Developing, 2 sources[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $7M | 2020-10-06 | [ LEAD ] |
No one else named on these rounds.